Cocaine Use & Co-occuring Opioid Use Disorders clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 18 years and up
This study will investigate the effects of intranasal administration of oxytocin, a social neuropeptide, on reducing cocaine use, enhancing therapeutic engagement, and susceptibility to stress-induced relapse in Veterans with cocaine use disorder and enrolled in opioid replacement therapy (ORT) program for co-occurring opioid use disorder (OUD).
San Francisco, California